They found that treatment with 2DG improved CAR-T cell killing capacity against lung cancer cell lines and cell lines of several other solid tumors, inhibited PD1/PD-L1 interactions, and prevented the development of an exhaustion phenotype [158]. Here, CD274 is linked to lung cancer.